Project Details
Description
The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.
Layman's description
Freenome is using a type of artificial intelligence, called machine learning, to identify patterns of cell-free biomarkers in blood to detect cancer early. The purpose of this prospective multi-center observational study is to validate a blood-based test for the detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.
| Acronym | PREEMPT CRC |
|---|---|
| Status | Finished |
| Effective start/end date | 20/05/20 → 30/05/24 |
Collaborative partners
- Freenome Holdings Inc. (lead)
- Cleveland Clinic Abu Dhabi
Keywords
- Artificial Intelligence
- Liquid Biopsy
- Blood Test Cancer
- Cancer Diagnostic
- Genomics
- Genomics Test
- CRC
- Cancer Screening
- Cancer Early Detection Test
- Screening
- Colonoscopy
- Machine Learning
- Freenome Test
- Colorectal Cancer (CRC)
- Colorectal Cancer Screening
- Intestinal Neoplasms
- Digestive System Neoplasms
- Neoplasms by Site
- Neoplasms
- Digestive System Diseases
- Gastrointestinal Diseases
- Intestinal Diseases
- Anatomical Pathological Conditions
- Glandular and Epithelial Neoplasms
- Neoplasms by Histologic Type
- Colorectal Neoplasms
- Colonic Neoplasms
- Adenoma
- Gastrointestinal Neoplasms
- Rectal Diseases
- Colonic Diseases
- Polyps
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.